Production (Stage)
Serina Therapeutics, Inc.
SER
$5.75
$0.01430.25%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.81M | -2.74M | 1.41M | -374.00K | -15.02M |
| Total Depreciation and Amortization | 17.00K | 56.00K | 56.00K | 57.00K | 25.00K |
| Total Amortization of Deferred Charges | -- | 8.00K | 8.00K | 307.00K | 22.00K |
| Total Other Non-Cash Items | 19.00K | -1.74M | -5.38M | -3.21M | 12.86M |
| Change in Net Operating Assets | 455.00K | -172.00K | 943.00K | -4.79M | 535.00K |
| Cash from Operations | -4.32M | -4.59M | -2.96M | -8.01M | -1.58M |
| Capital Expenditure | -- | -5.00K | -3.00K | 0.00 | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -5.00K | -3.00K | 0.00 | -14.00K |
| Total Debt Issued | -- | 110.00K | 8.00K | 525.00K | 2.40M |
| Total Debt Repaid | -- | -1.00K | -8.00K | -146.00K | -13.00K |
| Issuance of Common Stock | 1.00K | 4.92M | 86.00K | 4.99M | 4.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.92M | 0.00 | 0.00 | 0.00 | 337.00K |
| Cash from Financing | 4.92M | 5.03M | 86.00K | 5.37M | 2.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 595.00K | 437.00K | -2.88M | -2.64M | 1.14M |